Fang Ni
2021
In 2021, Fang Ni earned a total compensation of $1.7M as Chief Business Officer and Interim Chief Financial Officer at Black Diamond Therapeutics.
Compensation breakdown
| Bonus | $25,000 |
|---|---|
| Non-Equity Incentive Plan | $131,955 |
| Option Awards | $1,035,343 |
| Salary | $388,101 |
| Other | $94,171 |
| Total | $1,674,570 |
Ni received $1M in option awards, accounting for 62% of the total pay in 2021.
Ni also received $25K in bonus, $132K in non-equity incentive plan, $388.1K in salary and $94.2K in other compensation.
Rankings
In 2021, Fang Ni's compensation ranked 6,769th out of 12,415 executives tracked by ExecPay. In other words, Ni earned more than 45.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,769 out of 12,415 | 46th |
Division Manufacturing | 2,939 out of 5,501 | 47th |
Major group Chemicals And Allied Products | 1,296 out of 2,371 | 45th |
Industry group Drugs | 1,154 out of 2,092 | 45th |
Industry Biological Products, Except Diagnostic Substances | 273 out of 449 | 39th |
Source: SEC filing on April 28, 2022.
Ni's colleagues
We found three more compensation records of executives who worked with Fang Ni at Black Diamond Therapeutics in 2021.